Warner Bros Discovery initiates review of strategic alternatives-February 2024-www.financetom.com

Warner Bros Discovery initiates review of strategic alternatives

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Warner Bros Discovery initiates review of strategic alternatives

Oct 21, 2025 6:45 AM

Oct 21 (Reuters) - Warner Bros. Discovery ( WBD ) said

on Tuesday it has initiated a review of strategic alternatives

following unsolicited interest the company received from

multiple parties for both the entire company and Warner Bros.

(Reporting by Harshita Mary Varghese in Bengaluru)

Previous page： Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab Next page： Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab

Feb 3, 2025

08:36 AM EST, 02/03/2025 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) and AnaptysBio ( ANAB ) said Monday that they signed an agreement providing Vanda an exclusive global license to develop, manufacture, and commercialize imsidolimab. As part of the agreement, Vanda will make an upfront payment of $10 million and an additional $5 million for the existing drug supply...

Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group

Feb 3, 2025

08:33 AM EST, 02/03/2025 (MT Newswires) -- Baxter International's ( BAX ) former kidney care segment Vantive said Monday it has been acquired by funds managed by Carlyle Group ( CG ) . Vantive will now operate as an independent organ therapy company, it added. The deal was first announced by Baxter and Carlyle in August, under which Carlyle agreed...

Former RTX CEO Gregory Hayes to step down as chairman

Feb 3, 2025

Feb 3 (Reuters) - Former RTX CEO Gregory Hayes will step down as executive chairman and member of the board, the aerospace and defense major said on Monday. Hayes will remain an employee of RTX as a special advisor to CEO Christopher Calio, who will take on the role of chairman of the board, the company said. The transition will...

Tyson Foods Posts Q1 Earnings: Protein Conscious Customers Drive Demand, CEO Calls It Best Quarter In 2 Years

Feb 3, 2025

Shares of Tyson Foods Inc ( TSN ) are trading higher after the first-quarter FY25 earnings result. The company reported first-quarter FY25 sales growth of 2.3% year-on-year to $13.62 billion, beating the analyst consensus estimate of $13.44 billion. Sales volume of Beef increased 5.6% Y/Y, Pork declined 0.4%, Chicken climbed 1.5%, and Prepared Foods dropped 3.2%. Gross profit surged 33%...